Clinical Trial

Upper Limb Robot-Assisted Therapy in Patients with Guillain-Barré Syndrome

Study acronym: RAUL-Project
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Guillain-Barré Syndrome is an immune-mediated polyradiculoneuropathy, with around 100,000 new cases reported worldwide annually. The aim of this double-blind randomized controlled trial with a SHAM control group is to evaluate the effects of robot-assisted therapy, integrated with conventional therapy, on upper limb motor recovery in patients with GBS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-30.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-03-13
Trial Details
NCT Number NCT06620198
Lead Sponsor I.R.C.C.S. Fondazione Santa Lucia
Conditions Guillain Barré Syndrome
Enrollment 62 participants
Start Date 2024-10-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-18